
Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …

Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …

London-based healthcare communications agency Hanover has recruited Frances Beves as a director to join in August. Beves joins as a …

Red Door Unlimited has appointed a new director in Kimberly Santiago who joins from Porter Novelli’s sister agency Paradigm Communications. …

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …

Swiss-based Sophia Genetics that deals in data driven medicine has appointed Marylin Mermod Schule to be its chief financial officer. …

Manufacturer of the blockbuster hepatitis C treatment Sovaldi Gilead has seen its application for a patent in China rejected following …
A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …

Google has developed a health-tracking wearable that is not for the consumer market but rather designed to be utilised in …

UK life sciences membership organisation OBN has confirmed that its chief executive Jon Rees is stepping down in August after a decade …

The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.
Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …
The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

Scottish clinical stage biopharma firm Nucana has appointed Dr Martin Birkhofer as its chief medical officer. Birkhofer, an oncologist by training, …

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

The FDA has expanded the patient groups for whom Eisai’s epilepsy drug Fycompa is available to include people who have …

Healthcare comms agency GCI Health has promoted Claire Martin to associate director and Laura Starr to associate director and head …

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …